Unique ID issued by UMIN | UMIN000004174 |
---|---|
Receipt number | R000005010 |
Scientific Title | Effect of lactoferrin on viceral fat suppression in patients with chronic liver disease; a randomized, double blind, placebo-controlled, clinical trial |
Date of disclosure of the study information | 2010/10/01 |
Last modified on | 2013/04/02 15:32:13 |
Effect of lactoferrin on viceral fat suppression in patients with chronic liver disease; a randomized, double blind, placebo-controlled, clinical trial
Effect of lactoferrin on viceral fat suppression in patients with chronic liver disease
Effect of lactoferrin on viceral fat suppression in patients with chronic liver disease; a randomized, double blind, placebo-controlled, clinical trial
Effect of lactoferrin on viceral fat suppression in patients with chronic liver disease
Japan |
Chronic liver disease
Hepato-biliary-pancreatic medicine |
Others
NO
To investigate the efficacy of lactoferrin on visceral fat suppression in patients with chronic liver disease
Efficacy
Confirmatory
Pragmatic
Phase II
The change in viceral fat
(measured by helical CT scan)
1)The change in serum viral genome
2)The change in serum lipid or lipid marker levels
3)The change in serum ALT
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Medicine |
Subjects will be assinged randomly to lactoferrin treated group. Subjects will be received lactoferrin 300mg/day for 8weeks.
Subjects will be assinged randomly to placebo treated group. Subjects will be received placebo tablets for 8weeks.
Not applicable |
Not applicable |
Male and Female
1.The patient of chronic liver disease
2.BMI 23kg/m2 or more
1.Subjects who have already treated with anti-dyslipidemic agent
2.Sublects during pregnancy, feeding, intimation of pregnancy or intended pregnancy
3.Subjects who have already treated with interferon and ribavirin
4.Subjects who have already treated with steroids, immunosuppressive agent, and antitumor agent
34
1st name | |
Middle name | |
Last name | Manabu Morimoto |
Yokohama City University Medical Center
Gastroenterological Center
4-57 Urafune-cho, Minami-ku, Yokohama City, 232-0024, Japan
045-261-5656
1st name | |
Middle name | |
Last name | Akito Nozaki |
Yokohama City University Medical Center
Gastroenterological Center
4-57 Urafune-cho, Minami-ku, Yokohama City, 232-0024, Japan
045-261-5656
Yokohama City University Medical Center
Gastroenterological Center
None
Self funding
NO
横浜市立大学附属市民総合医療センター(神奈川県)
2010 | Year | 10 | Month | 01 | Day |
Unpublished
Completed
2010 | Year | 08 | Month | 17 | Day |
2010 | Year | 10 | Month | 01 | Day |
2013 | Year | 09 | Month | 01 | Day |
2010 | Year | 09 | Month | 08 | Day |
2013 | Year | 04 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005010
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |